These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32330937)

  • 1. Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II.
    Normand C; Linde C; Blomström-Lundqvist C; Stellbrink C; Gasparini M; Anker SD; Plummer C; Sarigul NU; Papiashvili G; Iovev S; Dickstein K
    Europace; 2020 Jun; 22(6):932-938. PubMed ID: 32330937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure.
    Lund LH; Svennblad B; Dahlström U; Ståhlberg M
    Eur J Heart Fail; 2018 Apr; 20(4):769-777. PubMed ID: 28949083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II.
    Lawin D; Israel CW; Linde C; Normand C; Dickstein K; Lober C; Gitt AK; Hindricks G; Stellbrink C;
    Clin Res Cardiol; 2020 Jul; 109(7):832-844. PubMed ID: 31811440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stricter criteria for Class I CRT indication suggested by the 2016 ESC Guidelines reliably exclude patients with a worse prognosis in comparison with the 2013 ESC indication criteria.
    Bertaglia E; Reggiani A; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Arena G; Marini M; Ricciardi G; Badolati S; Spotti A; Solimene F; Ferraro A; Migliore F; Botto GL; Malacrida M; Stabile G
    Int J Cardiol; 2018 Dec; 273():162-167. PubMed ID: 30217421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?
    Dickstein K; Normand C; Auricchio A; Bogale N; Cleland JG; Gitt AK; Stellbrink C; Anker SD; Filippatos G; Gasparini M; Hindricks G; Blomström Lundqvist C; Ponikowski P; Ruschitzka F; Botto GL; Bulava A; Duray G; Israel C; Leclercq C; Margitfalvi P; Cano Ó; Plummer C; Sarigul NU; Sterlinski M; Linde C
    Eur J Heart Fail; 2018 Jun; 20(6):1039-1051. PubMed ID: 29457358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy.
    Stabile G; Pepi P; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Rapacciuolo A; Arena G; Marini M; Pieragnoli P; Badolati S; Savarese G; Maglia G; Iuliano A; Botto GL; Malacrida M; Bertaglia E
    Heart Rhythm; 2018 Nov; 15(11):1675-1682. PubMed ID: 29665405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II.
    Normand C; Linde C; Bogale N; Blomström-Lundqvist C; Auricchio A; Stellbrink C; Witte KK; Mullens W; Sticherling C; Marinskis G; Sciaraffia E; Papiashvili G; Iovev S; Dickstein K
    Europace; 2019 Jun; 21(6):918-927. PubMed ID: 31157387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.
    Galand V; Linde C; Lellouche N; Mansourati J; Deharo JC; Sagnol P; Da Costa A; Horvilleur J; Defaye P; Boveda S; Steinbach M; Bru P; Rumeau P; Beard T; Younsi S; Dickstein K; Normand C; Leclercq C
    Arch Cardiovasc Dis; 2019 Nov; 112(11):713-722. PubMed ID: 31706879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II.
    Gatti P; Linde C; Benson L; Thorvaldsen T; Normand C; Savarese G; Dahlström U; Maggioni AP; Dickstein K; Lund LH
    Eur Heart J Qual Care Clin Outcomes; 2023 Dec; 9(8):741-748. PubMed ID: 37076773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis.
    Ranganathan D; Sharif Z; Murphy T; Mahon N; Sheahan CR; Normand C; Linde C; Dickstein K; Sheahan R
    Ir J Med Sci; 2020 Aug; 189(3):895-905. PubMed ID: 31981072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new ESC Guidelines for acute and chronic heart failure 2016].
    Oeing CU; Tschöpe C; Pieske B
    Herz; 2016 Dec; 41(8):655-663. PubMed ID: 27858115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II.
    Linde CM; Normand C; Bogale N; Auricchio A; Sterlinski M; Marinskis G; Sticherling C; Bulava A; Pérez ÓC; Maass AH; Witte KK; Rekvava R; Abdelali S; Dickstein K
    Eur J Heart Fail; 2018 Oct; 20(10):1457-1468. PubMed ID: 29806208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II.
    Koçyiğit D; Sarıgül NU; Altın AT; Çay S; Polat V; Saygı S; Gümrükçüoğlu HA; Gemici K; İkitimur B; Akyol A; Bilge AK; Başarıcı İ; Özcan EE; Demir M; Kabul HK; Ornek E; Normand C; Linde C; Dickstein K
    Anatol J Cardiol; 2020 Dec; 24(6):382-396. PubMed ID: 33253125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey.
    Sciaraffia E; Dagres N; Hernandez-Madrid A; Proclemer A; Todd D; Blomström-Lundqvist C
    Europace; 2015 Jan; 17(1):148-51. PubMed ID: 25552672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Zeppenfeld K; Merino JL; Kuck KH; Hindricks G
    Europace; 2015 Aug; 17 Suppl 4():iv1-72. PubMed ID: 26286028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy.
    Lyons KJ; Ezekowitz JA; Liang L; Heidenreich PA; Yancy CW; DeVore AD; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2017 May; 5(5):388-392. PubMed ID: 28449799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European CRT Survey: 1 year (9-15 months) follow-up results.
    Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
    Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European cardiac resynchronization therapy survey II: rationale and design.
    Dickstein K; Normand C; Anker SD; Auricchio A; Blomström-Lundqvisit C; Bogale N; Cleland J; Filippatos G; Gasparini M; Gitt A; Hindricks G; Kuck KH; Ponikowski P; Stellbrink C; Ruschitzka F; Linde C
    Europace; 2015 Jan; 17(1):137-41. PubMed ID: 25414481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.
    Goldstein SA; Mentz RJ; Hellkamp AS; Randolph TC; Fonarow GC; Hernandez A; Yancy CW; Al-Khatib SM
    Clin Cardiol; 2019 Feb; 42(2):256-263. PubMed ID: 30548280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.